---
pmid: '28381538'
title: Chemokine interactome mapping enables tailored intervention in acute and chronic
  inflammation.
authors:
- von Hundelshausen P
- Agten SM
- Eckardt V
- Blanchet X
- Schmitt MM
- Ippel H
- Neideck C
- Bidzhekov K
- Leberzammer J
- Wichapong K
- Faussner A
- Drechsler M
- Grommes J
- van Geffen JP
- Li H
- Ortega-Gomez A
- Megens RT
- Naumann R
- Dijkgraaf I
- Nicolaes GA
- Döring Y
- Soehnlein O
- Lutgens E
- Heemskerk JW
- Koenen RR
- Mayo KH
- Hackeng TM
- Weber C
journal: Sci Transl Med
year: '2017'
full_text_available: false
doi: 10.1126/scitranslmed.aah6650
---

# Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation.
**Authors:** von Hundelshausen P, Agten SM, Eckardt V, Blanchet X, Schmitt MM, Ippel H, Neideck C, Bidzhekov K, Leberzammer J, Wichapong K, Faussner A, Drechsler M, Grommes J, van Geffen JP, Li H, Ortega-Gomez A, Megens RT, Naumann R, Dijkgraaf I, Nicolaes GA, Döring Y, Soehnlein O, Lutgens E, Heemskerk JW, Koenen RR, Mayo KH, Hackeng TM, Weber C
**Journal:** Sci Transl Med (2017)
**DOI:** [10.1126/scitranslmed.aah6650](https://doi.org/10.1126/scitranslmed.aah6650)

## Abstract

1. Sci Transl Med. 2017 Apr 5;9(384):eaah6650. doi: 10.1126/scitranslmed.aah6650.

Chemokine interactome mapping enables tailored intervention in acute and chronic 
inflammation.

von Hundelshausen P(1)(2), Agten SM(3), Eckardt V(1), Blanchet X(1), Schmitt 
MM(1), Ippel H(3), Neideck C(1), Bidzhekov K(1), Leberzammer J(1), Wichapong 
K(3), Faussner A(1), Drechsler M(1), Grommes J(4), van Geffen JP(3), Li H(1), 
Ortega-Gomez A(1), Megens RT(1), Naumann R(5), Dijkgraaf I(3), Nicolaes GA(3), 
Döring Y(1)(2), Soehnlein O(1)(2)(6), Lutgens E(1)(2)(7), Heemskerk JW(2), 
Koenen RR(1)(3), Mayo KH(3)(8), Hackeng TM(3), Weber C(9)(2)(3).

Author information:
(1)Institute for Cardiovascular Prevention (IPEK), 
Ludwig-Maximilians-Universität München, Munich, Germany.
(2)German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart 
Alliance, Munich, Germany.
(3)Cardiovascular Research Institute Maastricht, Maastricht University, 
Maastricht, Netherlands.
(4)Department of Vascular Surgery, RWTH Aachen University, Aachen, Germany.
(5)Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, 
Germany.
(6)Department of Physiology and Pharmacology, Karolinksa Institutet, Stockholm, 
Sweden.
(7)Department of Medical Biochemistry, AMC, Amsterdam, Netherlands.
(8)Department of Biochemistry, Molecular Biology and Biophysics, University of 
Minnesota, Minneapolis, MN, USA.
(9)Institute for Cardiovascular Prevention (IPEK), 
Ludwig-Maximilians-Universität München, Munich, Germany. chweber@med.lmu.de.

Chemokines orchestrate leukocyte trafficking and function in health and disease. 
Heterophilic interactions between chemokines in a given microenvironment may 
amplify, inhibit, or modulate their activity; however, a systematic evaluation 
of the chemokine interactome has not been performed. We used immunoligand 
blotting and surface plasmon resonance to obtain a comprehensive map of 
chemokine-chemokine interactions and to confirm their specificity. 
Structure-function analyses revealed that chemokine activity can be enhanced by 
CC-type heterodimers but inhibited by CXC-type heterodimers. Functional 
synergism was achieved through receptor heteromerization induced by CCL5-CCL17 
or receptor retention at the cell surface via auxiliary proteoglycan binding of 
CCL5-CXCL4. In contrast, inhibitory activity relied on conformational changes 
(in CXCL12), affecting receptor signaling. Obligate CC-type heterodimers showed 
high efficacy and potency and drove acute lung injury and atherosclerosis, 
processes abrogated by specific CCL5-derived peptide inhibitors or knock-in of 
an interaction-deficient CXCL4 variant. Atheroprotective effects of CCL17 
deficiency were phenocopied by a CCL5-derived peptide disrupting CCL5-CCL17 
heterodimers, whereas a CCL5 α-helix peptide mimicked inhibitory effects on 
CXCL12-driven platelet aggregation. Thus, formation of specific chemokine 
heterodimers differentially dictates functional activity and can be exploited 
for therapeutic targeting.

Copyright © 2017, American Association for the Advancement of Science.

DOI: 10.1126/scitranslmed.aah6650
PMID: 28381538 [Indexed for MEDLINE]
